The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain

Author: Younger Jarred   Parkitny Luke   McLain David  

Publisher: Springer Publishing Company

ISSN: 0770-3198

Source: Clinical Rheumatology, Vol.33, Iss.4, 2014-04, pp. : 451-459

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content